Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 4812

BillFederalHousePassed House
Ensuring Compliance Against Drug Diversion Act of 2020
About This Bill
Passed
Latest Action · November 18, 2020
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Congress
116th (2019–2021)
Introduced
October 23, 2019
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
Ensuring Compliance Against Drug Diversion Act of 2020 This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances. It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.